Zoetis | ZTS - Gross Profit On Sales

Stock Price
127.42
Daily Change
0.69 0.54%
Monthly
1.39%
Yearly
-25.67%
Q1 Forecast
120.98

Zoetis reported $1.72B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
AbbVie USD 10.47B 605M Sep/2025
Align Technology USD 683.59M 44.39M Dec/2025
Bayer EUR 5.35B 1.02B Sep/2025
Bristol-Myers Squibb USD 8.79B 110M Sep/2025
Charles River Laboratories USD 311.39M 6.77M Sep/2025
Dentsply International USD 441M 49M Sep/2025
Eli Lilly USD 14.59B 1.48B Sep/2025
Henry Schein USD 1.03B 74M Sep/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
Illumina USD 759M 26M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
J&J USD 16.6B 118M Dec/2025
Laboratory Of America USD 1.03B 21.1M Sep/2025
Merck USD 13.42B 431M Sep/2025
Neogen USD 94.97M 2.11M Jun/2025
Pacira USD 130.92M 5M Sep/2025
Perrigo USD 377.1M 14.2M Sep/2025
Pfizer USD 3.54B 7.61B Sep/2025
Quest Diagnostics USD 910M 6M Sep/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Sanofi EUR 8.45B 3.02B Dec/2025
Zoetis USD 1.72B 96M Sep/2025